Wearable AI-ECG Age and Its Link to Atrial Fibrillation

Original Title: Wearable device derived electrocardiographic age and its association with atrial fibrillation

Journal: NPJ digital medicine

DOI: 10.1038/s41746-026-02344-8

Overview

This research introduces the PROPHECG-Age Single model, a deep-learning framework designed to estimate electrocardiographic age from single-lead wearable recordings. This approach enables continuous monitoring of cardiovascular aging in real-world settings. The study utilized a dataset of one million 12-lead electrocardiograms, which were converted into synthetic single-lead signals using a Cycle-Consistent Generative Adversarial Network. Validation in two independent wearable cohorts, S-Patch and Memo Patch, demonstrated mean absolute errors of 10.01 and 11.88 years, respectively. Statistical analysis revealed that the gap between predicted and chronological age is significantly associated with the presence of atrial fibrillation, showing a pooled adjusted odds ratio of 1.03 for every one-year increase in the age gap. Furthermore, the model established a positive correlation with atrial fibrillation burden, where each additional year in the age gap corresponded to a 0.8 percentage point increase in the time spent in an arrhythmic state.

Novelty

A primary challenge in developing wearable artificial intelligence models is the scarcity of large-scale single-lead datasets. This study addresses this by adopting a domain adaptation strategy that leverages existing hospital records. Instead of reconstructing 12-lead information from single-lead inputs, the researchers transformed 12-lead data into a single-lead format to train the model. This preserves the information content of established archives while ensuring compatibility with wearable hardware. The study also identifies a structural error floor associated with single-lead inputs, proving that the higher error rate compared to 12-lead models is a consequence of reduced spatial information rather than environmental noise. The research demonstrates high temporal consistency, with an intraclass correlation coefficient of 0.93 across multiple days, confirming that the derived age gap functions as a stable, personalized biomarker.

Potential Clinical / Research Applications

The ability to derive aging biomarkers from wearable devices offers several applications in clinical and research settings. In preventive cardiology, this model could facilitate risk management by identifying individuals with an accelerated cardiac aging profile before they develop symptomatic atrial fibrillation. Because the concept of an electrocardiographic age is intuitive, it may improve patient engagement by providing an understandable metric of heart health. In clinical trials, the model could serve as a digital endpoint to evaluate the impact of therapies on the rate of electrophysiological aging. Furthermore, the high reproducibility of the age gap makes it suitable for long-term population health studies aimed at understanding how environmental factors influence cardiovascular decline. By making the model weights publicly accessible, the researchers have provided a foundation for integrating personalized aging metrics into remote monitoring platforms, supporting continuous cardiovascular care.

Similar Posts

  • Deep Learning MRI Super-Resolution for Alzheimer’s Atrophy

    Original Title: Biomarkers Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association DOI: 10.1002/alz70856_107471 Overview Alzheimer's disease involves grey matter loss in regions like the hippocampus. Accurate atrophy measurement is essential for monitoring progression. Deformation Based Morphometry (DBM) quantifies these changes but is limited by the 1 millimeter cubed resolution of standard Magnetic Resonance Imaging. This study evaluates whether deep learning-based super-resolution improves the detection of subtle brain changes. The researchers used a dataset of 497 individuals from the Alzheimer’s Disease Neuroimaging Initiative. They compared standard 1 millimeter resolution images against high-resolution 0.5 millimeter isotropic images generated via an autoencoder-based model. By correlating measurements with ADASCog13 cognitive scores,…

  • Aviation Lessons for Human-AI Collaboration in Medicine

    Original Title: Flight rules for clinical AI: lessons from aviation for human-AI collaboration in medicine Journal: NPJ digital medicine DOI: 10.1038/s41746-026-02410-1 Overview Medicine and aviation are high-stakes fields where safety is paramount. Over the past decades, healthcare has adopted various aviation safety tools, such as surgical checklists and incident reporting systems. However, as artificial intelligence (AI) becomes more integrated into clinical workflows, new challenges arise that mirror aviation's earlier experiences with automation. The automation paradox describes a situation where increased automation erodes human skills and situational awareness, potentially leading to errors when the system fails. A study on AI-assisted colonoscopy showed a 6.0 percentage point absolute reduction in adenoma detection…

  • Cancer Detection in Breast MRI Screening via Explainable AI Anomaly Detection

    Title AI Anomaly Detection for Breast Cancer MRI One-Sentence Summary This study developed an artificial intelligence model using an anomaly detection approach that improved the accuracy of detecting and localizing breast cancer on MRI scans compared to a standard classification model, especially in realistic low-cancer-prevalence settings. Overview Researchers developed an AI model, Fully Convolutional Data Description (FCDD), to improve breast cancer detection on MRI. It uses an anomaly detection framework, training primarily on healthy tissue images to learn a representation of “normal” and then flagging deviations as potential cancers. The model was developed on 9,738 MRI exams and tested on internal and external datasets. It was compared against a traditional…

  • Regulating ICU AI: From Narrow Tools to Generalist Systems

    Original Title: The regulation of artificial intelligence in intensive care units: from narrow tools to generalist systems Journal: NPJ digital medicine DOI: 10.1038/s41746-026-02535-3 Overview Intensive care units represent highly data-intensive environments in healthcare, requiring continuous monitoring and rapid decision-making. While artificial intelligence has been explored for decades, its formal regulation as a medical device began in 1995. By May 2025, the number of approved artificial intelligence-enabled medical devices reached 1,016 in the United States. Many of these tools are designed for narrow, single-task applications such as interpreting radiological images or predicting sepsis. The emergence of generative artificial intelligence and large language models marks a shift toward generalist systems capable of…

  • Multimodal Cancer Prognosis via Clinical Prompt Integration

    Original Title: Multimodal deep learning for cancer prognosis prediction with clinical information prompts integration Journal: NPJ digital medicine DOI: 10.1038/s41746-025-02257-y Overview Survival analysis is a critical component of oncological care, providing the scientific basis for treatment planning and outcome evaluation. While multimodal deep learning has advanced this field by integrating pathology images and genomic data, clinical records are frequently underutilized due to their discrete and low-dimensional nature. This study introduces SurvPGC, a framework designed to bridge this gap by transforming clinical characteristics into high-dimensional embeddings using text templates and a language foundation model. The researchers validated SurvPGC using data from The Cancer Genome Atlas, specifically focusing on liver hepatocellular carcinoma,…

  • Deep Learning for HCC Biomarkers and Drug Discovery

    Original Title: Deep learning facilitated discovery of prognosis biomarkers and their ligands to improve liver cancer treatment Journal: International journal of surgery (London, England) DOI: 10.1097/JS9.0000000000003455 Overview The DLCP framework improves clinical prognosis for hepatocellular carcinoma by integrating genomics, transcriptomics, and epigenetics directly with survival outcomes. Analyzing 371 patients from The Cancer Genome Atlas, the model successfully stratified the cohort into 298 low-risk and 76 high-risk individuals, demonstrating significant survival differences with a P-value below 0.001. These results were confirmed through validation in an independent cohort of 232 patients. Key molecular signatures, including mutations in EIF2B4 and HCCS, were found to occur exclusively in the high-risk group. The analysis further…

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA